Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 11, 1999

View Archived Issues

Genset Adds To R&D Focus, Delays Time To Profitability

Genome Of Malaria Parasite Reveals Many Drug Targets

EPO To Grant Patents On GMOs, Cells and Genes

Ethics Committee Seeks Protections For Patients

OECD Starts To Look At Biotech Issues In EU

Investors Push CSL Higher After Deal With Red Cross

Creating Value Theme Of France Biotech Congress

UK Offers Grants To Move Biotech Forward

Elan Stops Development Of Antegren For Acute MS

New Venture Fund Created To Finance 10 New Companies

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...